TripSitter Clinic Ltd.

    TripSitter Clinic Ltd.

    CCSE:KETA
    - -
    CAD
    - -
    - -
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    - -
    0.02
    0.07
    - -
    - -
    - -
    Basic EPS, GAAP
    -0.03
    -2.04
    -0.28
    -0.05
    - -
    - -
    Free Cash Flow per Basic Share
    -0.02
    -0.35
    -0.21
    -0.03
    -0.01
    -0.01
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.11
    0.21
    -0.07
    -0.11
    -0.11
    -0.12
    Tangible Book Value per Share
    0.11
    0.21
    -0.07
    -0.11
    -0.11
    -0.12
    Basic Weighted Avg Shares
    6
    5
    7
    7
    7
    7
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    -2,607.52
    -381.04
    -2,493.62
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    - -
    -10
    -2
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    -11,717.35
    -382.75
    -2,181.49
    - -
    - -
    Working Capital
    1
    1
    - -
    -1
    -1
    -1
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    1
    1
    - -
    -1
    -1
    -1
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    -1,049.8
    - -
    - -
    - -
    - -

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Oct'25
    Jan'25
    Apr'26
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    7
    7
    7
    Market Capitalization
    - -
    - -
    - -

    Working Capital

    CAD

    •

    in mil. unless spec.
    Oct'25
    Jan'25
    Apr'26
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    1
    1
    1
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    2.7%
    Free Cash Flow
    - -
    - -
    -76.93%
    Net Income, GAAP
    - -
    - -
    -96.85%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    -0.05
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business